OPIANT PHARMACEUTICALS, INC. Quarterly Operating Income (Loss) in USD from Q3 2010 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Opiant Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2010 to Q3 2022.
  • Opiant Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$9.63M, a 343% decline year-over-year.
  • Opiant Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$31.5M, a 1199% decline year-over-year.
  • Opiant Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was $5.16M.
  • Opiant Pharmaceuticals, Inc. annual Operating Income (Loss) for 2020 was -$2.24M, a 121% decline from 2019.
  • Opiant Pharmaceuticals, Inc. annual Operating Income (Loss) for 2019 was $10.9M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$31.5M -$9.63M -$13.6M -343% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$17.9M -$11.4M -$13.6M -606% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 -$4.31M -$11.8M -$9.46M -407% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $5.16M $1.27M +$2.29M Oct 1, 2021 Dec 31, 2021 10-K 2022-03-15
Q3 2021 $2.87M $3.96M +$3.23M +445% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$365K $2.25M +$2.48M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$2.84M -$2.32M -$602K -35% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$2.24M -$1.01M -$1.75M -238% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 -$492K $727K -$9.87M -93.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $9.38M -$232K -$1.64M -116% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $11M -$1.72M +$105K +5.76% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $10.9M $734K +$10.4M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 $558K $10.6M +$11.5M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$11M $1.41M +$2.73M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$13.7M -$1.83M +$7.48M +80.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 -$21.2M -$9.62M -$13.2M -369% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-04
Q3 2018 -$7.99M -$940K +$1.9M +66.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$9.9M -$1.32M -$1.53M -727% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$8.36M -$9.31M -$6.49M -230% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$1.88M $3.58M -$7.06M -66.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-21
Q3 2017 $5.18M -$2.84M -$2.27M -391% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $7.45M $211K +$1.26M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $6.19M -$2.82M -$3.23M -785% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $9.42M $10.6M +$6.64M +166% Nov 1, 2016 Jan 31, 2017 10-Q 2017-03-15
Q3 2016 $2.78M -$579K +$10.5M +94.8% Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-04
Q2 2016 -$7.74M -$1.05M +$478K +31.3% May 1, 2016 Jul 31, 2016 10-KT 2018-03-07
Q1 2016 -$8.22M $412K +$2.25M Feb 1, 2016 Apr 30, 2016 10-Q 2017-06-14
Q4 2015 -$10.5M $4M +$6.77M Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-15
Q3 2015 -$17.2M -$11.1M -$10.3M -1360% Aug 1, 2015 Oct 31, 2015 10-Q 2016-12-15
Q2 2015 -$6.9M -$1.53M +$2.6M +62.9% May 1, 2015 Jul 31, 2015 10-K 2016-10-28
Q1 2015 -$9.5M -$1.84M -$1.29M -236% Feb 1, 2015 Apr 30, 2015 10-Q 2016-06-08
Q4 2014 -$8.2M -$2.77M +$2.32M +45.6% Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-15
Q3 2014 -$10.5M -$760K +$779K +50.6% Aug 1, 2014 Oct 31, 2014 10-Q 2015-12-14
Q2 2014 -$11.3M -$4.13M -$2.87M -229% May 1, 2014 Jul 31, 2014 10-K 2015-10-26
Q1 2014 -$8.43M -$547K +$32.7K +5.64% Feb 1, 2014 Apr 30, 2014 10-Q 2015-06-12
Q4 2013 -$8.46M -$5.09M +$1.15M +18.4% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-17
Q3 2013 -$9.61M -$1.54M -$807K -110% Aug 1, 2013 Oct 31, 2013 10-Q 2014-12-09
Q2 2013 -$8.81M -$1.25M +$351K +21.9% May 1, 2013 Jul 31, 2013 10-K 2014-10-27
Q1 2013 -$9.16M -$580K +$871K +60.1% Feb 1, 2013 Apr 30, 2013 10-Q 2014-06-10
Q4 2012 -$10M -$6.24M -$1.67M -36.4% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q3 2012 -$8.36M -$733K +$3.97M +84.4% Aug 1, 2012 Oct 31, 2012 10-Q 2013-12-16
Q2 2012 -$12.3M -$1.6M +$1.16M +41.9% May 1, 2012 Jul 31, 2012 10-K 2013-10-29
Q1 2012 -$13.5M -$1.45M +$3.95M +73.1% Feb 1, 2012 Apr 30, 2012 10-Q 2013-06-14
Q4 2011 -$17.4M -$4.57M -$3.58M -360% Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-18
Q3 2011 -$13.9M -$4.71M -$4.42M -1570% Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-20
Q2 2011 -$9.44M -$2.76M May 1, 2011 Jul 31, 2011 10-K/A 2012-11-01
Q1 2011 -$5.4M Feb 1, 2011 Apr 30, 2011 10-Q 2012-06-14
Q4 2010 -$995K Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-16
Q3 2010 -$282K Aug 1, 2010 Oct 31, 2010 10-Q 2011-12-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.